Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ehrlich

Showing results (201-210 of 278) with videos related to

Pageof 28
Sort By:
Plos One|August 31, 2011
H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer modelM Keith Howard, Nicolas Sabarth, Helga Savidis-Dacho, et al.
Journal of the Endocrine Society|February 2, 2026
Bone Age Delay in X-linked HypophosphatemiaJulio Soto, Rucha Anant Patki, Lauren J Ehrlich, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|October 7, 2004
Measurement of abdominal fat by CT compared to waist circumference and BMI in explaining the presence of coronary calciumJ K Snell-Bergeon, J E Hokanson, G L Kinney, et al.
Vaccine|August 17, 2011
Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programmeAlexandra Loew-Baselli, Eva Maria Poellabauer, Borislava G Pavlova, et al.
Seminars in Thrombosis and Hemostasis|July 16, 2010
Preclinical testing of human recombinant von Willebrand factor: ADAMTS13 cleavage capacity in animals as criterion for species suitabilityEva-Maria Muchitsch, Barbara Dietrich, Hanspeter Rottensteiner, et al.
Antimicrobial Agents and Chemotherapy|November 2, 2016
Randomized Trial of Food Effect on Pharmacokinetic Parameters of ABX464 Administered Orally to Healthy Male SubjectsDidier Scherrer, Regine Rouzier, Marine Cardona, et al.
Journal of Thrombosis and Haemostasis : JTH|May 9, 2009
Species-dependent variability of ADAMTS13-mediated proteolysis of human recombinant von Willebrand factorK Varadi, H Rottensteiner, S Vejda, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
ABX464 (obefazimod) for patients with COVID-19 at risk for severe disease: miR-AGE, a randomized, double-blind placebo-controlled trialPedro Giavina-Bianchi, Eric Cua, Karine Risso, et al.
Vaccine|May 11, 2010
Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccineEva Maria Pöllabauer, Sandor Fritsch, Borislava G Pavlova, et al.
Antibiotics & Chemotherapy (Northfield, Ill.)|February 19, 2014
6-Diazo-5-oxo-L-norleucine, a new tumor-inhibitory substance. I. Biologic studiesG L COFFEY, J EHRLICH, M W FISHER, et al.
Pageof 28

Showing results (201-210 of 278) with videos related to

Sort By:
Pageof 28
Plos One|August 31, 2011
H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer modelM Keith Howard, Nicolas Sabarth, Helga Savidis-Dacho, et al.
Journal of the Endocrine Society|February 2, 2026
Bone Age Delay in X-linked HypophosphatemiaJulio Soto, Rucha Anant Patki, Lauren J Ehrlich, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|October 7, 2004
Measurement of abdominal fat by CT compared to waist circumference and BMI in explaining the presence of coronary calciumJ K Snell-Bergeon, J E Hokanson, G L Kinney, et al.
Vaccine|August 17, 2011
Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programmeAlexandra Loew-Baselli, Eva Maria Poellabauer, Borislava G Pavlova, et al.
Seminars in Thrombosis and Hemostasis|July 16, 2010
Preclinical testing of human recombinant von Willebrand factor: ADAMTS13 cleavage capacity in animals as criterion for species suitabilityEva-Maria Muchitsch, Barbara Dietrich, Hanspeter Rottensteiner, et al.
Antimicrobial Agents and Chemotherapy|November 2, 2016
Randomized Trial of Food Effect on Pharmacokinetic Parameters of ABX464 Administered Orally to Healthy Male SubjectsDidier Scherrer, Regine Rouzier, Marine Cardona, et al.
Journal of Thrombosis and Haemostasis : JTH|May 9, 2009
Species-dependent variability of ADAMTS13-mediated proteolysis of human recombinant von Willebrand factorK Varadi, H Rottensteiner, S Vejda, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
ABX464 (obefazimod) for patients with COVID-19 at risk for severe disease: miR-AGE, a randomized, double-blind placebo-controlled trialPedro Giavina-Bianchi, Eric Cua, Karine Risso, et al.
Vaccine|May 11, 2010
Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccineEva Maria Pöllabauer, Sandor Fritsch, Borislava G Pavlova, et al.
Antibiotics & Chemotherapy (Northfield, Ill.)|February 19, 2014
6-Diazo-5-oxo-L-norleucine, a new tumor-inhibitory substance. I. Biologic studiesG L COFFEY, J EHRLICH, M W FISHER, et al.
Pageof 28